Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Inv. presentation
VIVUS INC (VVUS) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/08/2021 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
01/05/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/31/2020 EFFECT Form EFFECT - Notice of Effectiveness:
12/31/2020 EFFECT Form EFFECT - Notice of Effectiveness:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/29/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/29/2020 RW Form RW - Registration Withdrawal Request:
12/29/2020 RW Form RW - Registration Withdrawal Request:
11/16/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "VIVUS Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Date"
08/17/2020 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
08/11/2020 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
08/03/2020 CT ORDER Form CT ORDER - Confidential treatment order:
07/23/2020 CT ORDER Form CT ORDER - Confidential treatment order:
07/13/2020 8-K Quarterly results
07/07/2020 8-K Quarterly results
06/19/2020 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
06/19/2020 8-K Quarterly results
06/19/2020 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
06/08/2020 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
06/02/2020 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P. CAMPBELL, CA., June 2, 2020 — VIVUS, Inc. , a biopharmaceutical company, today announced that it has updated its agreement regarding its corporate debt with Icahn Enterprises Holdings L.P. , which holds a principal amount of approximately $170.2 million of the Company's Convertible Senior Notes."
05/08/2020 8-K Quarterly results
05/06/2020 8-K Quarterly results
05/06/2020 10-Q Quarterly Report for the period ended March 31, 2020
05/01/2020 8-K Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an...
Docs: "Agreement Regarding Convertible Notes, by and among VIVUS, Inc., the Noteholder and the Trustee",
"VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt CAMPBELL, CA., May 1, 2020 — VIVUS, Inc. , a biopharmaceutical company, today announced an agreement regarding its corporate debt with IEH Biopharma LLC, which holds a principal amount of approximately $170.1 million of the Company's Convertible Senior Notes with a maturity date of May 1, 2020. The Company does not currently have the ability to pay the principal amount of the Convertible Senior Notes held by IEH Biopharma. Under the terms of the agreement, the Company will pay IEH Biopharma $3.8 million in accrued and unpaid interest on the Convertible Senior Notes and IEH Biopharma will grant the Company a 30-day grace period , beginning today, for payment of the p..."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy